We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
-11.59%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$13.6B
AUM Growth
-$3.29B
Cap. Flow
-$1.2B
Cap. Flow %
-8.83%
Top 10 Hldgs %
51.07%
Holding
116
New
14
Increased
50
Reduced
18
Closed
20

Top Buys

Rank Stock Value
1
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
+$538M
2
RHT
Red Hat Inc
RHT
+$426M
3
AABA
Altaba Inc
AABA
+$393M
4
CI icon
Cigna
CI
+$220M
5
EQIX icon
Equinix
EQIX
+$196M

Top Sells

Rank Stock Value
1
AET
Aetna Inc
AET
+$1.51B
2
ESRX
Express Scripts Holding Company
ESRX
+$1.13B
3
COL
Rockwell Collins
COL
+$584M
4
DELL icon
Dell
DELL
+$430M
5
EVHC
Envision Healthcare Holdings Inc
EVHC
+$257M

Sector Composition

Rank Sector Weight
1 Communication Services 23.71%
2 Healthcare 20.15%
3 Technology 18.04%
4 Industrials 7.34%
5 Consumer Discretionary 4.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ILPT
76
Industrial Logistics Properties Trust
ILPT
$575M
$12M 0.09%
+610,545
New +$13M
APTX
77
DELISTED
Aptinyx Inc. Common Stock
APTX
$11.1M 0.08%
670,000
– –
TECX
78
Tectonic Therapeutic
TECX
$570M
$10.8M 0.08%
54,167
+15,417
+40% +$4.7M
ZEAL
79
DELISTED
Zealand Pharma A/S American Depositary Shares
ZEAL
$10.4M 0.08%
900,000
– –
PRNB
80
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
$9.59M 0.07%
350,000
+225,000
+180% +$5.8M
LRMR icon
81
Larimar Therapeutics
LRMR
$436M
$8.79M 0.06%
147,917
+12,500
+9% +$1.23M
MLNX
82
DELISTED
Mellanox Technologies, Ltd.
MLNX
$8.78M 0.06%
+95,000
New +$8.07M
VYGR icon
83
Voyager Therapeutics
VYGR
$189M
$8.55M 0.06%
909,158
– –
ASMB icon
84
Assembly Biosciences
ASMB
$524M
$7.92M 0.06%
29,167
+4,167
+17% +$1.21M
VOYA icon
85
Voya Financial
VOYA
$9.2B
$7.43M 0.05%
185,000
– –
THOR
86
DELISTED
Synthorx, Inc. Common Stock
THOR
$6.71M 0.05%
+386,092
New +$5.6M
TBIO
87
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$3.75M 0.03%
500,000
+50,000
+11% +$366K
GCVRZ
88
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$3.28M 0.02%
6,827,805
– –
BLCM
89
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$2.92M 0.02%
100,000
-113,663
-53% -$5.04M
CRNX icon
90
Crinetics Pharmaceuticals
CRNX
$8.9B
$2.86M 0.02%
95,365
-46,450
-33% -$1.31M
ITCI
91
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$2.85M 0.02%
250,000
– –
AVA icon
92
Avista
AVA
$3.22B
$2.67M 0.02%
62,900
-1,407,100
-96% -$69.7M
PFNX
93
DELISTED
Pfenex Inc.
PFNX
$1.91M 0.01%
600,000
– –
TYME
94
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$1.11M 0.01%
300,857
-105,000
-26% -$295K
VTAK icon
95
Catheter Precision
VTAK
$977K
– –
-1
Closed -$2.36M
CHRS icon
96
Coherus Oncology
CHRS
$194M
– –
-700,000
Closed -$11.6M
KALV
97
DELISTED
KalVista Pharmaceuticals
KALV
– –
-200,000
Closed -$4.42M
NTLA icon
98
Intellia Therapeutics
NTLA
$1.57B
– –
-550,000
Closed -$15.7M
PBYI icon
99
Puma Biotechnology
PBYI
$413M
– –
-410,000
Closed -$18.8M
SLDB icon
100
Solid Biosciences
SLDB
$857M
– –
-19,667
Closed -$13.9M
1 2 3
4
5

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Farallon Capital Management held 116 positions worth $13.6B, down 19% from $16.9B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Farallon Capital Management withdrew a net $1.2B in Q4 2018, closing 20 positions and reducing 18 holdings. Its most notable exit was Aetna Inc, an estimated $1.51B position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 24% of assets, up from 13% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Farallon Capital Management opened a new position in Red Hat Inc worth $472M.

  • Farallon Capital Management's largest Q4 2018 buy was Red Hat Inc: 2,685,000 shares worth $472M.
  • Farallon Capital Management added most to Twenty-First Century Fox, Inc. Class A in Q4 2018, an estimated $538M increase.
  • Farallon Capital Management's biggest Q4 2018 reduction was Dell, cutting an estimated $430M.
  • Farallon Capital Management fully exited Aetna Inc in Q4 2018, selling an estimated $1.51B.
  • Farallon Capital Management's ten largest holdings make up 51% of its $13.6B portfolio in Q4 2018.
  • Farallon Capital Management opened 14 new positions and closed 20 in Q4 2018.
  • Farallon Capital Management's portfolio value fell 19% quarter-over-quarter to $13.6B.

Based on Farallon Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.